Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. senior Avg
|
New words:
AEs, aimed, Arena, ATM, bacterial, barrier, Bio, bore, cholesterol, chosen, chronically, clarification, cohort, concept, Crohn, cumbersome, dehydrogenase, epithelial, examination, Extortion, Feature, genetically, Gossamer, holder, hydroxysteroid, immune, immunosuppression, inhibitor, innate, intestinal, Jardiance, Leerink, lipoprotein, medicinal, mg, molecule, multi, multiplied, October, pathway, perpetrated, Protagonist, refinancing, regimen, rescind, SD, shelf, statistically, superseded, SVB, translocation, Ulcerative, week
Removed:
AG, agonism, Akero, Allergan, anticipating, asymptomatic, biopsy, clearance, clinically, CymaBay, daily, denied, diagnostic, discomfort, dosed, educate, Eli, Enanta, endpoint, ENYO, fourth, Gilead, histologic, impractical, interact, Intercept, Inventiva, landscape, lieu, Lilly, listing, Madrigal, measuring, mentioned, metabolic, morbidity, mortality, NAFLD, NGM, Nordisk, Novo, OCA, optimizing, orally, penetration, Pharma, plc, potency, potent, premarket, procedure, purposefully, rare, rat, refine, regular, reliable, repeated, SA, sample, Sanofi, Shire, Squibb, surrogate, survival, syndrome, targeted, tested, thousand, timetable, transplant, undergoing, undiagnosed, Viking
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view